The grant from The Mark Foundation for Cancer Research will establish The Mark Foundation Center for Immunotherapy, Immune Signaling, and Radiation at the University of Pennsylvania, which will seek to better understand the interconnected relationship between novel forms of radiation therapy, important signaling pathways between cancer and immune cells, and the immune system’s ability to kill cancer. Five projects will bring together multidisciplinary teams of basic science and clinical researchers to answer these key questions. Read the announcement.
The united states and many other nations are launching a life-threatening experiment. They are rapidly and perhaps prematurely easing restrictions on […]
“There has not been a large funding community around infectious diseases, except for the Gates Foundation and Wellcome Trust, maybe […]